BiotechTube
COUNTRIES
🇨🇭

Switzerland

Western Europe

Switzerland punches far above its weight in biotech, with Basel as a global pharmaceutical hub (Roche, Novartis). The Swiss biotech ecosystem benefits from exceptional talent, favorable tax policies, and proximity to major pharma headquarters.

Biotech Market Cap
$779.3B
Public Companies
31
Total Companies
325
30D Performance
-1.23%

BIOTECH MARKET CAP INDEX

$779.3B+2935.4%ALL

BIOTECH HUBS

BaselZurichGenevaLausanne

COMPANIES

#CompanyValuation
1
Roche
RocheROG.SW		$324.4B
2
Novartis
NovartisNVS		$292.9B
3
Galderma Group
Galderma GroupGALD.SW		$43.6B
4
Lonza
LonzaLONN.SW		$43.3B
5
Sandoz Group
Sandoz GroupSDZ.SW		$33.7B
6
Bachem
BachemBANB.SW		$6.1B
7
Galenica
GalenicaGALE.SW		$5.7B
8
Ypsomed
YpsomedYPSN.SW		$4.9B
9
CRISPR Therapeutics
CRISPR TherapeuticsCRSP		$4.6B
10
Siegfried Holding
Siegfried HoldingSFZN.SW		$4.1B
11
BB Biotech
BB BiotechBION.SW		$3.1B
12
Tecan
TecanTECN.SW		$2.0B
13
HBM Healthcare Investments
HBM Healthcare InvestmentsHBMN.SW		$1.8B
14
Oculis Holding AG
Oculis Holding AGOCS		$1.5B
15
MoonLake Immunotherapeutics
MoonLake ImmunotherapeuticsMLTX		$1.3B
16
Kuros Biosciences
Kuros BiosciencesKURN.SW		$1.1B
17
PolyPeptide Group
PolyPeptide GroupPPGN.SW		$1.1B
18
Idorsia
IdorsiaIDIA.SW		$1.0B
19
Basilea Pharmaceutica
Basilea PharmaceuticaBSLN.SW		$807.2M
20
ADC Therapeutics
ADC TherapeuticsADCT		$517.1M
Showing 1–20 of 325 companies
Page 1 of 17
← Back to countries